Cambridge, United Kingdom

James Terence Collins



 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of James Terence Collins in Inhaler Technology

Introduction

James Terence Collins is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of inhaler devices, particularly focusing on the design and functionality of these essential medical tools. His innovative approach has led to the development of a unique inhaler device that enhances the delivery of medicaments.

Latest Patents

James Terence Collins holds 1 patent for his invention of an inhaler device. This device features medicament carriers that contain individual pockets or blisters of powdered medicament, which are covered by a lidding sheet, such as a lidding foil. The design includes a common actuator that controls the movement of an indexing system for advancing a dose and an opening system for releasing the dose. Notably, the progression of the opening system is disproportional to the progression of the indexing system during the movement of the common actuator, which enhances the efficiency of the inhaler.

Career Highlights

Collins has been associated with Sandoz AG, where he has contributed his expertise in the development of inhalation technologies. His work has been instrumental in improving the usability and effectiveness of inhalers, making them more accessible for patients who rely on these devices for their respiratory needs.

Collaborations

Throughout his career, James has collaborated with several talented individuals, including David Gregory Ahern and Robin Craig Cocker. These collaborations have fostered a creative environment that has led to innovative solutions in inhaler technology.

Conclusion

James Terence Collins is a distinguished inventor whose work in inhaler devices has made a significant impact on the medical field. His innovative designs and collaborations continue to shape the future of respiratory care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…